Operative Specimen Handling and Evaluation of Resection Margins

  • Caroline Sophie VerbekeEmail author


Specimen grossing is a key step in the pathology examination of pancreatic resection specimens. Specimen dissection with optimal display of pathological changes and extensive tissue sampling are important determinants of the quality of pathology reporting. This chapter provides a detailed discussion of the macroscopic examination procedure and assessment of the specimen margins with reference to current (inter-)national guidelines and recommendations.


Common Bile Duct Superior Mesenteric Artery Pancreatic Head Main Pancreatic Duct Superior Mesenteric Vein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The author wishes to thank Øystein H. Horgmo, medical illustrator, University of Oslo, for the assistance with the illustrations.

Disclosure Statement

The author has no conflicting interests to declare.


  1. 1.
    Feakins R, Campbell F, Verbeke CS. Survey of UK histopathologists’ approach to the reporting of resection specimens for carcinomas of the pancreatic head. J Clin Pathol. 2013;66:715–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Westgaard A, Laronningen S, Mellem C, Eide TJ, Clausen OP, Møller B, et al. Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma. Eur J Cancer. 2009;45:2850–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Verbeke CS, Gladhaug IP. Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg. 2012;99:1036–49.CrossRefPubMedGoogle Scholar
  4. 4.
    Chandrasegaram MD, Goldstein D, Simes J, Gebski V, Kench JG, Gill AJ, et al. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg. 2015;102:1459–72.CrossRefPubMedGoogle Scholar
  5. 5.
    Campbell F, Foulis AK, Verbeke CS. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct. The Royal College of Pathologists; 2010. Available from:
  6. 6.
    Cancer of the Exocrine Pancreas, Ampulla of Vater and Distal Common Bile Duct. The Royal College of Pathologists of Australasia; 2014. Available from:
  7. 7.
    Seufferlein T, Porzner M, Heinemann V, Tannapfel A, Stuschke M, Uhl W. Ductal pancreatic adenocarcinoma. Dtsch Arztebl Int. 2014;111:396–402.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Pancreatic adenocarcinoma. In: NCCN clinical practice guidelines in oncology; 2015. Available from:
  9. 9.
    Verbeke CS. Resection margins in pancreatic cancer. Surg Clin North Am. 2013;93:647–62.CrossRefPubMedGoogle Scholar
  10. 10.
    Campbell F, Verbeke CS. Pathology of the pancreas – a practical approach. London: Springer; 2013.CrossRefGoogle Scholar
  11. 11.
    Nelson H, Hunt KK, Veeramachaneni N, Blair S, Chang G, Halverson A, et al. Operative standards for cancer surgery. Volume 1: breast, lung, pancreas, colon. American College of Surgeons and the Alliance for Clinical Trials in Oncology. Wolters Kluwer, Philadelphia; 2015. p. 181–272.Google Scholar
  12. 12.
    Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, Konishi I, et al. Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepato Biliary Pancreat Surg. 2004;11:402–8.CrossRefGoogle Scholar
  13. 13.
    Adsay NV, Basturk O, Saka B, Bagci P, Ozdemir D, Balci S, et al. Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors. Am J Surg Pathol. 2014;38:480–93.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93:1232–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651–60.CrossRefPubMedGoogle Scholar
  16. 16.
    Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, et al. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2010;251:1003–10.CrossRefPubMedGoogle Scholar
  17. 17.
    Björnstedt M, Franzén L, Glaumann H, Nordlinder H, Palmqvist R, Rissler P, et al. Gastrointestinal pathology pancreas and peri-ampullary region. KVAST Study Group for hepatopancreatobiliary pathology; 2012. Available from
  18. 18.
    Sobin LH, Gospodarowicz MK, Wittekind C, editors. UICC: TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.Google Scholar
  19. 19.
    Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer staging manual. 7th ed. New York: American Joint Committee on Cancer: Springer-Verlag; 2010.Google Scholar
  20. 20.
    Hruban RH, Klimstra DS, Pitman MB. Tumors of the pancreas. AFIP atlas of tumor pathology. 6th ed. Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2007.Google Scholar
  21. 21.
    Verbeke CS, Knapp J, Gladhaug IP. Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment. Histopathology. 2011;59:1111–21.CrossRefPubMedGoogle Scholar
  22. 22.
    Verbeke C. Morphological heterogeneity in ductal adenocarcinoma of the pancreas – does it matter? Pancreatology. 2016;16:295–301. Epub ahead of print.Google Scholar
  23. 23.
    Verbeke C, Sheridan M, Scarsbrook A, Albazaz R, Smith A, Menon K, et al. How accurate is size assessment of pancreatic head cancers by radiology and pathology? Pancreatology. 2010;10:300.Google Scholar
  24. 24.
    Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155:977–88.CrossRefPubMedGoogle Scholar
  25. 25.
    Kamposioras K, Anthoney A, Fernández Moro C, Cairns A, Smith AM, Liaskos C, et al. Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer. Br J Surg. 2014;101:89–99.CrossRefPubMedGoogle Scholar
  26. 26.
    Kim J, Reber HA, Dry SM, Elashoff D, Chen SL, Umetani N, et al. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut. 2006;55:1598–605.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Washington K, Berlin J, Branton P, Burgart LJ, Carter DK, Compton CC, et al. Protocol for the examination of specimens from patients with carcinoma of the exocrine pancreas. Coll Am Pathol. 2013;. Available from:
  28. 28.
    Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89:327–34.CrossRefPubMedGoogle Scholar
  29. 29.
    Chang DK, Johns AL, Merrett ND, Gill AJ, Colvin EK, Scarlett CJ, et al. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol. 2009;27:2855–62.CrossRefPubMedGoogle Scholar
  30. 30.
    Verbeke C, Löhr M, Karlsson JS, Del Chiaro M. Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties. Cancer Treat Rev. 2015;41:17–26.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Department of PathologyOslo University HospitalOsloNorway
  2. 2.Institute of Clinical MedicineUniversity of OsloOsloNorway

Personalised recommendations